ADAMA (000553) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
30 Oct, 2026Executive summary
Q3 revenue was $897m, down 4%; adjusted sales were $809m, down 5%, and adjusted EBITDA fell 31% to $66m amid weaker demand, pricing pressure, higher costs and European weather disruption.
9M reported sales were $2,997m, down 1%, while adjusted sales rose 2% to $2,740m; reported and adjusted figures reflect different bases.
9M reported EBITDA rose 10.4% in USD, while adjusted EBITDA fell 11% to $305m; adjusted net loss widened to $34m from $1m.
Cost discipline and differentiated-product mix supported resilience; the next strategic phase targets profitable growth from the platform built through Fight Forward.
Financial highlights
Q3 revenue was $897m, down 4% in USD; volume fell 4% and prices 2%, partly offset by FX. Adjusted sales were $809m, down 5%.
Q3 adjusted gross profit fell 15% to $205m; adjusted gross margin was 25.3% versus 28.3%.
Q3 adjusted net loss was $79m versus $22m; reported net loss was $117m versus $42m.
9M reported net loss narrowed to RMB 344.9m from RMB 422.8m, while adjusted net loss was $34m versus $1m.
9M adjusted gross profit fell 1% to $777m; adjusted gross margin was 28.4% versus 29.2%.
Outlook and guidance
The next strategic phase, spanning 2026 and beyond into 2027, aims to convert a stable platform into profitable growth across differentiated products and commodities.
Management planned to continue pursuing free cash flow, cost discipline and profitable growth in difficult market conditions.
Regional recovery and El Niño impacts for 2027 remained uncertain; management declined to forecast the weather effect.
The expected operational and financial impact of global tariff-policy changes was immaterial; Neot Hovav had returned to normal operations, with site-damage effects expected to be non-material.
Latest events from ADAMA
- Destocking and price pressure cut FY earnings; cost and inventory actions strengthened cash flow.000553
Q4 2023 - Net profit rebounded to RMB 432.6 million as margins improved despite revenue decline.000553
Q2 2026 - Q1 2026 sales and net profit rose, while EBITDA declined amid higher costs and price pressures.000553
Q1 2026 - EBITDA rose 25% in 2025 despite a 2% sales drop, with strong cash flow and improved margins.000553
Q4 2025 - Sales and margins improved, with net loss narrowing and operational efficiency gains achieved.000553
Q3 2025 - Q2 2025 saw sales growth, margin expansion, and positive adjusted net income amid price pressure.000553
Q2 2025 - Margins and cash flow improved in Q3 2024 despite lower sales and ongoing pricing pressure.000553
Q3 2024 - Sales fell 16% in H1 2024, but margins and cash flow improved through cost discipline.000553
Q2 2024 - Net profit rebounded and EBITDA rose 21% as margins and cash flow improved despite lower sales.000553
Q1 2025